From: Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori, Japan
 | 2017–2018 | 2018–2019 | 2019- 2020 | 2020–2021 | 2021- | ||||
---|---|---|---|---|---|---|---|---|---|
 | Apr-Sep | Oct-Mar | Apr-Sep | Oct-Mar | Apr-Sep | Oct-Mar | Apr-Sep | Oct-Mar | Apr-Sep |
All samples (Cases) | 30,783 | 29,862 | 31,929 | 36,268 | 44,540 | 45,432 | 40,017 | 39,317 | 35,974 |
E. faecium (Cases) | 257 | 218 | 267 | 264 | 256 | 295 | 266 | 277 | 251 |
 (The percentage of E. faecium in all samples) | (0.83%) | (0.73%) | (0.84%) | (0.73%) | (0.57%) | (0.65%) | (0.66%) | (0.70%) | (0.70%) |
VREf data (Cases) | 0 | 1 | 54 | 178 | 169 | 55 | 28 | 14 | 1 |
VREf / all samples | 0.00% | 0.00% | 0.17% | 0.49% | 0.38% | 0.12% | 0.07% | 0.04% | 0.00% |
VREf / E. faecium | 0.00% | 0.46% | 20.22% | 67.42% | 66.02% | 18.64% | 10.53% | 5.05% | 0.40% |
Blood culture (Cases) | 8585 | 8606 | 8668 | 8499 | 9667 | 9118 | 8980 | 10,513 | 8847 |
E. faecium in blood culture (Cases) | 38 | 33 | 42 | 34 | 46 | 65 | 39 | 60 | 58 |
 (The percentage of E. faecium in blood culture) | (0.44%) | (0.38%) | (0.48%) | (0.40%) | (0.48%) | (0.71%) | (0.43%) | (0.57%) | (0.66%) |
VREf in blood culture (Cases) | 0 | 0 | 1 | 10 | 8 | 2 | 0 | 0 | 0 |
VREf / blood culture | 0.00% | 0.00% | 0.01% | 0.12% | 0.08% | 0.02% | 0.00% | 0.00% | 0.00% |
VREf / E. faecium in blood culture | 0.00% | 0.00% | 2.38% | 29.41% | 17.39% | 3.08% | 0.00% | 0.00% | 0.00% |
Active screenig for VREf in 13 hospitals (Cases) | Â | Â | Â | Â | 20,676 | 15,636 | 10,598 | 5122 | Â |
 Simultaneous screening for all inpatients (Cases) |  |  |  |  | 5478 | 3087 | 1397 | 153 |  |
 Screening for new admissions (Cases) |  |  |  |  | 15,198 | 12,549 | 9201 | 4969 |  |
New VREf from active screening (Cases) | Â | Â | Â | Â | 23 | 12 | 2 | 0 | Â |
New VREf / active screening | Â | Â | Â | Â | 0.11% | 0.08% | 0.02% | 0.00% | Â |